Imprinted overinduction of hepatic cyp2B1 and 2B2 in adult rats neonatally exposed to phenobarbital

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 991-999

  Agrawal, Arun K ^a   Shapiro, Bernard H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE 16BETA HYDROXYLASE; ANDROSTENEDIONE DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 2B1; LIVER ENZYME; PHENOBARBITAL; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG METABOLISM; DRUG PROTEIN BINDING; ENZYME INDUCTION; ENZYME MECHANISM; FEMALE; GROWTH INHIBITION; LIVER METABOLISM; MALE; NEWBORN; NONHUMAN; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; ENZYME INDUCTION; FEMALE; GROWTH HORMONE; LIVER; MALE; NADPH-FERRIHEMOPROTEIN REDUCTASE; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STEROID HYDROXYLASES;

EID: 0030438461     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. AGRAWAL, A. K., PAMPORI, N. A. AND SHAPIRO, B. H.: Neonatal phenobarbital-induced defects in age- and sex-specific growth hormone profiles regulating monooxygenases. Am. J. Physiol. 268: E439-E445, 1995a.
2. AGRAWAL, A. K., PAMPORI, N. A. AND SHAPIRO, B. H.: Thin-layer chromatographic separation of regioselective and stereospecific androgen metabolites. Anal. Biochem. 224: 455-457, 1995b.
3. AGRAWAL, A. K. AND SHAPIRO, B. H.: Phenobarbital induction of hepatic CYP2B1 and CYP2B2: Pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Mol. Pharmacol. 49: 523-531, 1996.
4. ALBRIGHT, P. S. AND BURNHAM, W. M.: Development of a new pharmacological seizure model: Effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia 21: 681-689, 1980.
5. ANONYMOUS: Germ-free life. Lancet II: 933-934, 1953.
6. BAGLEY, D. M. AND HAYES, J. R.: Xenobiotic imprinting of the hepatic monooxygenase system. Effects of neonatal phenobarbital administration. Biochem. Pharmacol. 34: 1007-1014, 1985a.
7. BAHLEY, D. M. AND HAYES, J. R.: Neonatal phenobarbital imprinting of hepatic microsomal enzymes in adult rats: Modulation by neonatal testosterone presence. Toxicol. Appl. Pharmacol. 79: 227-235, 1985b.
8. CARL, G. F. AND SMITH, M. L.: Chronic primidone treatment in the rat: An animal model of primidone therapy. Res. Commun. Chem. Pathol. Pharmacol. 61: 365-376, 1988.
9. CHOMCZYNSKI, P. AND SACCHI, N.: Single step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
10. CLEMENS, L. G., POPHAM, T. V. AND RUPPERT, P. H.: Neonatal treatment of hamsters with barbiturate alters adult sexual behavior. Dev. Psychobiol. 12: 49-59, 1979.
11. CRESTEIL, T., BEAUNE, P., CELIER, C., LEROUX, J. P. AND GUENGERICH, F. P.: Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: Effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. J. Pharmacol. Exp. Ther. 236: 269-276, 1986.
12. FALK, J. E.: Haems. I. Determination as pyridine haemochromes. In Porphyrins and Metalloporphyrins, their General, Physical and Coordination Chemistry, and Laboratory Methods, pp. 181-188, Elsevier, Amsterdam, 1964.
13. FARIS, R. A. AND CAMPBELL, T. C.: Exposure of newborn rats to pharmacologically active compounds may permanently alter carcinogen metabolism. Science 211: 719-721, 1981.
14. GIACHELLI, C. M. AND OMIECINSKI, C. J.: Regulation of cytochrome P-450b and P-450e mRNA expression in the developing rat. Hybridization to synthetic oligodeoxyribonucleotide probes. J. Biol. Chem. 261: 1359-1363, 1986.
15. GOLD, E., GORDIS, L., TONASCIA, J. AND SZKLO, M.: Increased risk of brain tumors in children exposed to barbiturates. J. Natl. Cancer Inst. 61: 1031-1034, 1978.
16. GUENGERICH, P. F.: Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48: 2946-2954, 1988.
17. GUPTA, C., SONAWANE, B. R., YAFFE, S. J. AND SHAPIRO, B. H.: Phenobarbital exposure in utero: Alterations in female reproductive function in rats. Science 208: 508-510, 1980.
18. GUPTA, C., YAFFE, S. J. AND SHAPIRO, B. H.: Prenatal exposure to phenobarbital permanently decreases testosterone and causes reproductive dysfunction. Science 216: 640-642, 1982.
19. HALES, B. F. AND JAIN, R.: Effects of phenobarbital and β-naphthoflavone on the activation of cyclophosphamide to mutagenic metabolites in vitro by liver and kidney from male and female rats. Biochem. Pharmacol. 29: 2031-2037, 1980.
20. ISHIZAKI, T., YOKOCHI, K., CHIBA, K., TABUCHI, T. AND WAGATSUM, T.: Placental transfer of anticonvulsants (phenobarbital, phenytoin, valproic acid) and the elimination from neonates. Pediatr. Pharmacol. 1: 291-303, 1981.
21. JANSSON, J.-O., EDÉN, S. AND ISAKSSON, O.: Sexual dimorphism in the control of growth hormone secretion. Endocr. Rev. 6: 128-150, 1985.
22. JANSSON, J.-O., EKBERG, S., ISAKSSON, O. G. P. AND EDÉN, S.: Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat. Endocrinology 114: 1287-1294, 1984.
23. MACLEOD, J. N., PAMPORI, N. A. AND SHAPIRO, B. H.: Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J. Endocrinol. 131: 395-399, 1991.
24. MACLEOD, J. N. AND SHAPIRO, B. H.: Repetitive blood sampling in unrestrained and unstressed mice using a chronic indwelling right atrial catheterization apparatus. Lab. Anim. Sci. 38: 603-608, 1988.
25. MIDDAUGH, L. D., THOMAS, T. N., SIMPSON, L. W. AND ZEMP, J. W.: Effects of prenatal maternal injections of phenobarbital on brain neurotransmitters and behavior of young C57 mice. Neurobehav. Toxicol. Teratol. 3: 271-275, 1981.
26. MITCHELL, J. R., SMITH, C. V., LAUTERBURG, B. H., HUGHES, H., CORCORAN, G. B. AND HORNING, E. C.: Reactive metabolites and the pathophysiology of acute lethal cell injury. In Drug Metabolism and Drug Toxicity, ed. by J. R. Mitchell and M. G. Horning, pp. 301-319, Raven Press, New York, 1984.
27. OMIECINSKI, C. J., WALZ JR., F. G. AND VLASUK, G. P.: Phenobarbital induction of rat liver cytochrome P-450b and P-450e. Quantitation of specific RNAs by hybridization to synthetic oligodeoxyribonucleotide probes. J. Biol. Chem. 260: 3274-3250, 1985.
28. OMURA, T. AND SATO, R.: The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. J. Biol. Chem. 239: 2370-2378, 1964.
29. PAMPORI, N. A., AGRAWAL, A. K. AND SHAPIRO, B. H.: Renaturalizing the sexually dimorphic profile of circulating growth hormone in hypophysectomized rats. Acta Endocrinol. 124: 283-289, 1991.
30. PAMPORI, N. A., PAMPORI, M. K. AND SHAPIRO, B. H.: Dilution of the chemiluminescence reagents reduces the background noise on Western blots. BioTechniques 18: 588-590, 1995.
31. PAMPORI, N. A. AND SHAPIRO, B. H.: Testicular regulation of sexual dimorphisms in the ultradian profiles of circulating growth hormone in the chicken. Eur. J. Endocrinol. 131: 313-318, 1994a.
32. PAMPORI, N. A. AND SHAPIRO, B. H.: Over-expression of CYP2C11, the major male-specific form of hepatic cytochrome P450, in the presence of nominal pulses of circulating growth hormone in adult male rats neonatally exposed to low levels of monosodium glutamate. J. Pharmacol. Exp. Ther. 271: 1067-1073, 1994b.
33. PAMPORI, N. A AND SHAPIRO, B. H.: Subnormal concentrations in the feminine profile of circulating growth hormone enhance expression of female-specific CYP2C12. Biochem. Pharmacol. 47: 1999-2004, 1994c.
34. PARK, B. K. AND BRECKENRIDGE, A. M.: Clinical implications of enzyme induction and enzyme inhibition. Clin. Pharmacokinet. 6: 1-24, 1981.
35. RAMSDEN, R., SOMMER, K. M. AND OMIECINSKI, C. J.: Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J. Biol. Chem. 268: 21722-21726, 1993.
36. REINISCH, J. M., SANDERS, S. A., MORTENSEN, E. L. AND RUBIN, D. B.: In utero exposure to phenobarbital and intelligence deficits in adult men. J. Am. Med. Assoc. 274: 1518-1525, 1995.
37. RETTIE, A. E., RETTENMEIER, A. W., HOWALD, W. N. AND BAILLIE, T. A.: Cytochrome P-450-catalyzed formation of delta-4-VPA, a toxic metabolite of valproic acid. Science 235: 890-893, 1987.
38. RYAN, D. E. AND LEVIN, W.: Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45: 153-239, 1990.
39. SCHUETZ, E. G., SCHUETZ, J. D., MAY, B. AND GUZELIAN, P. S.: Regulation of cytochrome P-450b/e and P-450p gene expression by growth hormone in adult rat hepatocytes cultured on a reconstituted basement membrane. J. Biol. Chem. 265: 1188-1192, 1990.
40. SHAPIRO, B. H.: Sexually dimorphic response of rat hepatic monooxygenases to low-dose phenobarbital. Biochem. Pharmacol. 35: 1766-1768, 1986.
41. 5-steroid oxidoreductase inhibitor. Proc. Soc. Exp. Biol. Med. 149: 896-899, 1975.
42. SHAPIRO, B. H., MACLEOD, J. N., PAMPORI, N. A., MORRISSEY, N. A., LAPENSON, J. J. AND WAXMAN, D. J.: Signalling elements in the ultradian rhythm of growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology 125: 2935-2944, 1989.
43. SHAPIRO, B. H., PAMPORI, N. A., LAPENSON, D. P. AND WAXMAN, D. J.: Growth hormone-dependent and -independent sexually dimorphic regulation of phenobarbital-induced hepatic cytochromes P450 2B1 and 2B2. Arch. Biochem. Biophys. 312: 234-239, 1994.
44. SHAPIRO, B. H. AND SZCZOTKA, S. M.: Androgenic repression of hexobarbitone metabolism and action in Crl:CD-1(ICR)BR mice. Br. J. Pharmacol. 81: 49-54, 1984.
45. SOBRIAN, S. K. AND NANDEDKAR, A. K. N.: Prenatal antiepileptic drug exposure alters seizure susceptibility in rats. Pharmacol. Biochem. Behav. 24: 1381-1391, 1986.
46. SOLIMAN, K. F. A. AND RICHARDSON, S. D.: Effects of prenatal exposure to phenobarbital on the development of monoamine oxidase and glucocorticoids. Gen. Pharmacol. 14: 369-371, 1983.
47. STROBEL, H. W. AND DIGNAM, J. D.: Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol. 52: 89-96, 1978.
48. VALERINO, D. M., VESELL, E. S., AURORI, K. C. AND JOHNSON, A. O.: Effects of various barbiturates on hepatic microsomal enzymes. A comparative study. Drug Metab. Dispos. 2: 448-457, 1974.
49. VELDHUIS, J. D. AND JOHNSON, M. L.: Cluster analysis: A simple, versatile and robust algorithm for endocrine pulse detection. Am. J. Physiol. 250: E486-E493, 1986.
50. VORHEES, C. V.: Fetal anti-convulsant syndrome in rats: Dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione and phenobarbital exposure on the structural and functional development of the offspring. J. Pharmacol. Exp. Ther. 227: 274-287, 1983.
51. VORHEES, C. V.: Fetal anticonvulsant syndrome in rats: Effects of postnatal behavior and brain amino acid content. Neurobehav. Toxicol. Teratol. 7: 471-482, 1985.
52. WANI, J. H., AGRAWAL, A. K. AND SHAPIRO, B. H.: Neonatal phenobarbital-induced persistent alterations in plasma testosterone profiles and testicular function. Toxicol. Appl. Pharmacol. 137: 295-300, 1996.
53. WAXMAN, D. J. AND AZAROFF, L.: Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J. 281: 577-592, 1992.
54. WAXMAN, D. J., KO, A. AND WALSH, C.: Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J. Biol. Chem. 258: 11937-11947, 1983.
55. WAXMAN, D. J., LAPENSON, D. P., PARK, S. S., ATTISANO, C. AND GELBOIN, H. V.: Monoclonal antibodies inhibitory to rat hepatic cytochrome P-450: P-450 form specificities and use as probes for cytochrome P-450-dependent steroid hydroxylations. Mol. Pharmacol. 32: 615-624, 1987.
56. WAXMAN, D. J., MORRISSEY, J. J., NAIK, S. AND JAUREGUI, H. O.: Phenobarbital induction of cytochrome P-450. High-level and long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response. Biochem. J. 271: 113-119, 1990.
57. WAXMAN, D. J., PAMPORI, N. A., RAM, P. A., AGRAWAL, A. K. AND SHAPIRO, B. H.: Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic P450. Proc. Natl. Acad. Sci. U.S.A. 88: 6868-6872, 1991.
58. YAFFE, S. J. AND DORN, L. D.: Effects of prenatal treatment with phenobarbital. Dev. Pharmacol. Ther. 15: 215-223, 1990.
59. YAMAZOE, Y., SHIMADA, M., MURAYAMA, N. AND KATO, R.: Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J. Biol. Chem. 262: 7423-7428, 1987.